In addition, we also determined that known downstream signaling molecules activated by interferon-gamma receptors associated with macrophages, namely STAT1, IRF1, and IRF5, were also correlated with poor OS outcomes in tumor samples. The gene discussed is STAT1; the disease is neoplasm.